MarketPeel
Insider Trading Intelligence
JE

Joseph Edelman

ALDX
10% OWNER · ALDEYRA THERAPEUTICS, INC. · CIK 0001164426
FILING MIX · LIFETIME70%/30%
BUYS
130
SELLS
56
TOTAL VALUE
$544.31M
COMPANIES
16
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
51,986,915
AVG SELL PX
$3.01
TRADE KIND
SHOWING 186 / 186
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
124 backtested trades · 8 horizons · 44 pending
Forward-return performance of every backtestable P/S trade by Joseph Edelman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d124+61.29%+1.33%+0.06%+1.28%-3.62%0.94
14d124+54.03%-0.68%+1.03%-1.71%-5.18%-1.03
30d124+41.94%-1.78%+1.01%-2.79%-7.36%-1.37
60d124+50.81%-5.04%+3.41%-8.45%-10.82%-4.40
90d124+47.58%-1.31%+6.10%-7.41%-13.59%-2.23
180d124+66.13%+46.94%+10.95%+35.99%+6.72%3.09
1y124(18 pending)+50.94%+86.00%+18.93%+67.07%+9.21%3.06
2y124(26 pending)+41.84%+173.83%+31.93%+141.90%-41.95%3.29
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ALDX · 5,875,851 shares · as of Apr 3, 2025
02,837,5215,675,0438,512,56411,350,08520212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 130 buys / 56 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LONA
LEONABIO, INC.
PURCHASEGRANT
Stock grant
28,00028,000Jun 23, 2026Jun 24, 2026View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
60,00060,000Jun 11, 2026Jun 15, 2026View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
77,50077,500Jun 10, 2026Jun 11, 2026View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
555,555$9.00$5.00M10,786,658Apr 17, 2026Apr 23, 2026View →
LONA
LEONABIO, INC.
PURCHASEGRANT
Stock grant
28,00028,000Apr 9, 2026Apr 13, 2026View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
400,000400,000Mar 25, 2026Apr 23, 2026View →
MGTX
MEIRAGTX HOLDINGS PLC
SALE
300,0000Mar 25, 2026Apr 23, 2026View →
MGTX
MEIRAGTX HOLDINGS PLC
SALE
400,0000Mar 25, 2026Apr 23, 2026View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
300,000300,000Mar 25, 2026Apr 23, 2026View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
8,912,655$5.61$49.99M8,912,655Mar 9, 2026Mar 11, 2026View →
MGTX
MEIRAGTX HOLDINGS PLC
SALE
2,300,000$7.91$18.19M10,231,103Dec 31, 2025Jan 2, 2026View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
3,213$3.90$12.5K14,026Nov 13, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
28,597$3.90$111.5K124,859Nov 13, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
7,862$4.06$31.9K153,456Nov 12, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
883$4.06$3.6K17,239Nov 12, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
4,783$4.31$20.6K161,318Nov 11, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
537$4.31$2.3K18,122Nov 11, 2025Nov 13, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
1,869$4.54$8.5K18,659Nov 10, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
16,633$4.54$75.5K166,101Nov 10, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
17,746$4.75$84.2K182,734Nov 7, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
1,993$4.75$9.5K20,528Nov 7, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
3,247$5.18$16.8K22,521Nov 6, 2025Nov 10, 2025View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
28,902$5.18$149.7K200,480Nov 6, 2025Nov 10, 2025View →
ADGM
ADAGIO MEDICAL HOLDINGS, INC.
PURCHASE
1,344,999$0.18$248.3K1,344,999Oct 20, 2025Oct 22, 2025View →
ADGM
ADAGIO MEDICAL HOLDINGS, INC.
PURCHASE
1,344,999$0.18$248.3K1,344,999Oct 20, 2025Oct 22, 2025View →
ADGM
ADAGIO MEDICAL HOLDINGS, INC.
PURCHASE
1,344,999$0.18$248.3K1,344,999Oct 20, 2025Oct 22, 2025View →
ADGM
ADAGIO MEDICAL HOLDINGS, INC.
PURCHASE
2,190,496$1.60$3.51M2,190,496Oct 20, 2025Oct 22, 2025View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
1,500,000$2.75$4.12M1,500,000Aug 1, 2025Aug 5, 2025View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
700,000$2.75$1.93M5,292,556Aug 1, 2025Aug 5, 2025View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
45,00045,000Jun 12, 2025Jun 16, 2025View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
77,50077,500Jun 12, 2025Jun 13, 2025View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
298,886$1.34$400.5K3,104,139May 1, 2025May 1, 2025View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
437,881$1.41$617.4K3,403,025Apr 30, 2025May 1, 2025View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
250,000$1.41$352.5K3,840,906Apr 29, 2025Apr 29, 2025View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
215,283$1.56$335.8K4,090,906Apr 28, 2025Apr 29, 2025View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
1,054,669$1.95$2.06M4,306,189Apr 25, 2025Apr 29, 2025View →
ALDX
ALDEYRA THERAPEUTICS, INC.
SALE
3,400,000$1.42$4.83M5,875,851Apr 3, 2025Apr 7, 2025View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
5,000,000$4.03$20.15M11,833,539Feb 19, 2025Feb 21, 2025View →
ADGM
ADAGIO MEDICAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
64,1679,675,684Jan 22, 2025Feb 14, 2025View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASE
1,250,000$4.00$5.00M12,531,103Aug 12, 2024Aug 14, 2024View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
45,00045,000Jun 14, 2024Jun 17, 2024View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
34,40034,400Jun 11, 2024Nov 18, 2024View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
45,00045,000Jun 6, 2024Jun 7, 2024View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASE
2,353,000$8.50$20.00M5,360,858Apr 11, 2024Apr 15, 2024View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
37,712$4.74$178.8K9,275,851Apr 5, 2024Apr 8, 2024View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
140,281$4.67$655.1K9,238,139Apr 4, 2024Apr 8, 2024View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
309,847$4.09$1.27M9,097,858Apr 3, 2024Apr 3, 2024View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
186,051$3.44$640.0K8,788,011Apr 2, 2024Apr 3, 2024View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
8,374$3.25$27.2K8,601,960Apr 1, 2024Apr 3, 2024View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
3,410,713$5.53$18.86M6,833,539Jan 11, 2024Jan 12, 2024View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
115,774$7.24$838.2K7,099,182Dec 29, 2023Dec 29, 2023View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
126,116$7.08$892.9K6,983,408Dec 28, 2023Dec 29, 2023View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
79,726$7.20$574.0K6,857,292Dec 27, 2023Dec 29, 2023View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
54,652$6.49$354.7K6,777,566Dec 26, 2023Dec 26, 2023View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
250,000$6.67$1.67M6,722,914Dec 22, 2023Dec 26, 2023View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
200,000$6.17$1.23M6,472,914Dec 21, 2023Dec 26, 2023View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
277,008$5.36$1.48M6,272,914Dec 19, 2023Dec 19, 2023View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
456,923$5.41$2.47M5,995,906Dec 18, 2023Dec 19, 2023View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
500,000$5.97$2.98M5,538,983Dec 15, 2023Dec 19, 2023View →
ALDX
ALDEYRA THERAPEUTICS, INC.
SALE
306,499$1.74$533.3K8,593,586Oct 18, 2023Oct 18, 2023View →
ALDX
ALDEYRA THERAPEUTICS, INC.
SALE
2,450,000$1.60$3.92M8,900,085Oct 16, 2023Oct 18, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
250,000$20.00$5.00M3,074,542Sep 28, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
250,000$19.99$5.00M250,000Sep 28, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
75,477$17.28$1.30M2,528,231Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
52,691$18.24$961.1K2,580,922Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
117,996$20.03$2.36M2,787,603Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
37,911$11.05$418.9K2,270,473Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
36,939$21.00$775.7K2,824,542Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
5,703$7.65$43.6K2,213,456Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
30,511$13.92$424.7K2,421,659Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
88,685$19.11$1.69M2,669,607Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
77,837$11.81$919.3K2,348,310Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
13,687$8.30$113.6K2,227,143Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
5,419$9.52$51.6K2,232,562Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
27,769$16.00$444.3K2,452,754Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
42,838$12.84$550.0K2,391,148Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
3,326$14.61$48.6K2,424,985Sep 26, 2023Sep 28, 2023View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
45,00045,000Jun 15, 2023Jun 20, 2023View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
20,00020,000Jun 8, 2023Jun 12, 2023View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
20,00020,000Jun 8, 2023Jun 12, 2023View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
9,6509,650Jun 6, 2023Jun 8, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
200$5.93$1.2K2,207,753Jun 6, 2023Jun 6, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
78,468$5.98$469.2K2,207,553Jun 5, 2023Jun 6, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
64,630$5.93$383.3K2,129,085Jun 2, 2023Jun 6, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
7,500$5.59$41.9K2,064,455Jun 1, 2023Jun 1, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
10,000$5.28$52.8K2,056,955May 31, 2023Jun 1, 2023View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
1,805,4161,805,416May 31, 2023Jun 2, 2023View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
3,610,832$2.49$9.00M11,469,117May 31, 2023Jun 2, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
17,500$5.34$93.5K2,046,955May 30, 2023Jun 1, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
22,500$5.27$118.6K2,029,455May 26, 2023May 26, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
37,500$5.18$194.3K2,006,955May 25, 2023May 26, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
25,000$5.48$137.0K1,969,455May 24, 2023May 26, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
27,500$5.45$149.9K1,944,455May 23, 2023May 23, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
27,300$5.12$139.8K1,916,955May 22, 2023May 23, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
25,200$4.62$116.4K1,889,655May 19, 2023May 23, 2023View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASE
4,347,826$5.75$25.00M11,281,103May 5, 2023May 15, 2023View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
9,6509,650Dec 13, 2022Dec 15, 2022View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
365,5363,422,826Dec 2, 2022Dec 6, 2022View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
2,163,120$7.05$15.25M3,057,290Dec 2, 2022Dec 6, 2022View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
73,10773,107Dec 2, 2022Dec 6, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
15,000$7.85$117.8K11,350,085Aug 10, 2022Aug 11, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
100,000$7.50$750.0K11,335,085Aug 9, 2022Aug 11, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
97,000$7.24$702.3K11,235,085Aug 8, 2022Aug 10, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
141,000$6.95$980.0K11,138,085Aug 5, 2022Aug 9, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
95,100$6.17$586.8K10,997,085Aug 4, 2022Aug 8, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
100,000$5.84$584.0K10,901,985Aug 3, 2022Aug 5, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
412,406$5.59$2.31M10,801,985Aug 2, 2022Aug 4, 2022View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
300,000300,000Aug 2, 2022Apr 23, 2026View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
400,000400,000Aug 2, 2022Apr 23, 2026View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
144,185$5.05$728.1K10,389,579Aug 1, 2022Aug 3, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
222,123$5.03$1.12M10,245,394Jul 29, 2022Aug 2, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
119,392$5.00$597.0K10,023,271Jul 28, 2022Aug 1, 2022View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
1,428,571$2.10$3.00M5,038,983Jul 5, 2022Jul 5, 2022View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
86,46786,467Jun 15, 2022Jun 17, 2022View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
51,00051,000Jun 7, 2022Jun 9, 2022View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
15,00015,000Jun 7, 2022Jun 13, 2022View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
15,00015,000Jun 7, 2022Jun 13, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
157,515$22.22$3.50M5,321,032Apr 18, 2022Apr 18, 2022View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
5,924,170$4.22$25.00M7,858,285Apr 12, 2022Apr 14, 2022View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASE
200,000$5.36$1.07M9,111,151Dec 8, 2021Dec 9, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
1,200,000$19.80$23.76M5,163,517Oct 25, 2021Oct 25, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
7,306$13.40$97.9K2,487,019Oct 12, 2021Oct 13, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
12,475$12.03$150.1K2,503,676Oct 11, 2021Oct 13, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
9,351$13.15$123.0K2,494,325Oct 11, 2021Oct 13, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
5,038$12.90$65.0K2,518,613Oct 8, 2021Oct 13, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
2,462$13.66$33.6K2,516,151Oct 8, 2021Oct 13, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
13,082$14.80$193.6K2,523,937Oct 7, 2021Oct 13, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
286$15.05$4.3K2,523,651Oct 7, 2021Oct 13, 2021View →
ADMA
ADMA BIOLOGICS, INC.
SALE
137,495$1.12$154.0K13,262,375Sep 30, 2021Sep 30, 2021View →
ADMA
ADMA BIOLOGICS, INC.
SALE
82,505$1.16$95.7K13,399,870Sep 29, 2021Sep 30, 2021View →
ADMA
ADMA BIOLOGICS, INC.
SALE
40,603$1.22$49.5K13,482,375Sep 28, 2021Sep 30, 2021View →
ADMA
ADMA BIOLOGICS, INC.
SALE
250,000$1.23$307.5K13,522,978Sep 27, 2021Sep 29, 2021View →
ADMA
ADMA BIOLOGICS, INC.
SALE
250,000$1.26$315.0K13,772,978Sep 24, 2021Sep 29, 2021View →
ADMA
ADMA BIOLOGICS, INC.
SALE
780,000$1.27$990.6K14,022,978Sep 23, 2021Sep 28, 2021View →
ADMA
ADMA BIOLOGICS, INC.
SALE
350,352$1.24$434.4K14,802,978Aug 19, 2021Aug 19, 2021View →
ADMA
ADMA BIOLOGICS, INC.
SALE
552,380$1.29$712.6K15,153,330Aug 18, 2021Aug 19, 2021View →
ADMA
ADMA BIOLOGICS, INC.
SALE
879,092$1.35$1.19M15,705,710Aug 17, 2021Aug 19, 2021View →
VYNE
VYNE THERAPEUTICS INC.
SALE
250,000$1.74$435.0K4,935,057Aug 16, 2021Aug 18, 2021View →
VYNE
VYNE THERAPEUTICS INC.
SALE
250,000$1.84$460.0K5,185,057Aug 13, 2021Aug 17, 2021View →
VYNE
VYNE THERAPEUTICS INC.
SALE
338,897$2.23$755.7K5,435,057Aug 12, 2021Aug 16, 2021View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
15,00015,000Jun 10, 2021Jun 14, 2021View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
15,00015,000Jun 10, 2021Jun 14, 2021View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASE
2,914,1138,911,151Jun 9, 2021Jun 11, 2021View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASE
5,500,000$10.00$55.00M5,997,038Jun 9, 2021Jun 11, 2021View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASE
7,063$10.05$71.0K497,038May 24, 2021Jun 11, 2021View →
VYNE
VYNE THERAPEUTICS INC.
SALE
1,000,000$3.67$3.67M5,773,954May 6, 2021May 7, 2021View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
1,200,000$12.50$15.00M9,903,879May 3, 2021May 4, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
550,000$17.00$9.35M2,537,019Apr 27, 2021Apr 27, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
1,195,7920Apr 27, 2021Apr 27, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
949,9920Apr 27, 2021Apr 27, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
879,703879,703Apr 27, 2021Apr 27, 2021View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
1,107,3161,987,019Apr 27, 2021Apr 27, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
304,136$16.44$5.00M3,963,517Apr 8, 2021Apr 9, 2021View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
2,608,695$5.75$15.00M13,412,552Mar 23, 2021Mar 23, 2021View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASE
4,219,409$2.37$10.00M27,095,819Jan 28, 2021Feb 1, 2021View →
SCYX
SCYNEXIS INC
SALE
33,849$8.95$302.9K1,800,000Jan 22, 2021Jan 26, 2021View →
SCYX
SCYNEXIS INC
SALE
285,151$8.16$2.33M1,833,849Jan 22, 2021Jan 26, 2021View →
SCYX
SCYNEXIS INC
SALE
95,000$7.38$701.1K2,120,000Jan 21, 2021Jan 26, 2021View →
SCYX
SCYNEXIS INC
SALE
185,000$7.43$1.37M2,215,000Jan 20, 2021Jan 26, 2021View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
1,368,421$9.50$13.00M8,703,879Jan 19, 2021Jan 21, 2021View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
347,332$9.21$3.20M7,132,790Jan 8, 2021Jan 11, 2021View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
50,000$7.60$380.0K7,335,458Jan 8, 2021Jan 11, 2021View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
152,668$10.21$1.56M7,285,458Jan 8, 2021Jan 11, 2021View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
500,000$8.13$4.07M6,785,458Jan 7, 2021Jan 11, 2021View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
4,054,054$3.70$15.00M10,803,857Dec 10, 2020Dec 15, 2020View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASE
500,000$12.85$6.42M6,933,277Nov 23, 2020Nov 24, 2020View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASE
3,200,000$4.25$13.60M6,285,458Jul 9, 2020Jul 13, 2020View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
30,00030,000Jun 16, 2020Jun 18, 2020View →
MGTX
MEIRAGTX HOLDINGS PLC
PURCHASEGRANT
Stock grant
25,00025,000Jun 2, 2020Jun 4, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
39,035,3250May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
773,327773,327May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
16,232,5110May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
339,604$8.63$2.93M1,471,620May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
141,2210May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
1,132,0161,132,016May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
26,666,6660May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
339,6040May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
470,7391,244,066May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
76,172$16.00$1.22M1,309,115May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
141,221$8.63$1.22M1,385,287May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
SALE
183,174$16.00$2.93M1,288,446May 5, 2020May 6, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASE
625,000$16.00$10.00M1,934,115May 5, 2020May 29, 2020View →
LYRA
LYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,50014,500Apr 30, 2020May 1, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
1,071,428$14.00$15.00M3,659,381Apr 17, 2020Apr 20, 2020View →
ADMA
ADMA BIOLOGICS, INC.
PURCHASE
500,000$2.10$1.05M16,584,802Mar 19, 2020Mar 23, 2020View →
ADMA
ADMA BIOLOGICS, INC.
PURCHASE
4,563,700$3.50$15.97M16,084,802Feb 11, 2020Feb 11, 2020View →
Other insiders · ALDX
Loading peer insiders…
About this filer
CIK 0001164426
ROLE
10% Owner
PRIMARY
ALDX
COMPANIES
16
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001164426DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback